LAPOINTE ANTHONY GREGG
CIK: 0001331860
Director
Primary company: SOLIGENIX, INC. (SNGX)
LAPOINTE ANTHONY GREGG is a corporate insider at SOLIGENIX, INC. (SNGX) filing SEC Form 4 transactions. 90 transactions across 7 companies, totaling $200,000 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
SOLIGENIX, INC. SNGX | Disposition | 192 | $156.00 | $30K | 0 | 10/12/2026 Filed: 10/12/2026 | Filing → |
SOLIGENIX, INC. SNGX | Disposition | 121 | $247.20 | $30K | 0 | 10/12/2026 Filed: 10/12/2026 | Filing → |
SOLIGENIX, INC. SNGX | Disposition | 63 | $472.80 | $30K | 0 | 10/12/2026 Filed: 10/12/2026 | Filing → |
SOLIGENIX, INC. SNGX | Disposition | 128 | $232.80 | $30K | 0 | 10/12/2026 Filed: 10/12/2026 | Filing → |
SOLIGENIX, INC. SNGX | Disposition | 74 | $400.80 | $30K | 0 | 10/12/2026 Filed: 10/12/2026 | Filing → |
SOLIGENIX, INC. SNGX | Disposition | 54 | $549.60 | $30K | 0 | 10/12/2026 Filed: 10/12/2026 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 5,750 | - | - | 18,250 | 5/15/2026 Filed: 5/15/2026 | Filing → |
SOLIGENIX, INC. SNGX | Award | 17,647 | - | - | 17,647 | 6/20/2025 Filed: 6/20/2025 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 26,550 | - | - | 26,550 | 6/11/2025 Filed: 6/12/2025 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 3,000 | - | - | 3,000 | 5/23/2025 Filed: 5/28/2025 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 2,500 | - | - | 12,500 | 5/23/2025 Filed: 5/28/2025 | Filing → |
SOLIGENIX, INC. SNGX | Award | 8,646 | - | - | 8,646 | 12/12/2024 Filed: 12/13/2024 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 14,100 | - | - | 14,100 | 6/5/2024 Filed: 6/6/2024 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 30,000 | - | - | 30,000 | 5/25/2024 Filed: 5/29/2024 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 25,000 | - | - | 100,000 | 5/25/2024 Filed: 5/29/2024 | Filing → |
SOLIGENIX, INC. SNGX | Award | 38,136 | $0.00 | $0 | 38,136 | 12/15/2023 Filed: 12/15/2023 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 30,000 | $0.00 | $0 | 30,000 | 5/26/2023 Filed: 7/12/2023 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Award | 25,000 | $0.00 | $0 | 75,000 | 5/26/2023 Filed: 7/12/2023 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 14,100 | $0.00 | $0 | 14,100 | 6/2/2023 Filed: 6/6/2023 | Filing → |
SOLIGENIX, INC. SNGX | Award | 46,154 | $0.00 | $0 | 129,747 | 11/17/2022 Filed: 11/21/2022 | Filing → |
SOLIGENIX, INC.
SNGX
Type
Disposition
Shares
192
Price
$156.00
Value
$30K
SOLIGENIX, INC.
SNGX
Type
Disposition
Shares
121
Price
$247.20
Value
$30K
SOLIGENIX, INC.
SNGX
Type
Disposition
Shares
63
Price
$472.80
Value
$30K
SOLIGENIX, INC.
SNGX
Type
Disposition
Shares
128
Price
$232.80
Value
$30K
SOLIGENIX, INC.
SNGX
Type
Disposition
Shares
74
Price
$400.80
Value
$30K
SOLIGENIX, INC.
SNGX
Type
Disposition
Shares
54
Price
$549.60
Value
$30K
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
5,750
Price
-
Value
-
SOLIGENIX, INC.
SNGX
Type
Award
Shares
17,647
Price
-
Value
-
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
26,550
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
3,000
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
2,500
Price
-
Value
-
SOLIGENIX, INC.
SNGX
Type
Award
Shares
8,646
Price
-
Value
-
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
14,100
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
30,000
Price
-
Value
-
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
25,000
Price
-
Value
-
SOLIGENIX, INC.
SNGX
Type
Award
Shares
38,136
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
30,000
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
14,100
Price
$0.00
Value
$0
SOLIGENIX, INC.
SNGX
Type
Award
Shares
46,154
Price
$0.00
Value
$0
AI Agent
Try asking...